Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM

NCT01114282 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: velcade
DRUG: Pralatrexate

Sponsor

Stanford University

Collaborators

[object Object]